Nisreen Shamseddine

Nisreen Shamseddine, PharmD, MS, MBA, is a seasoned professional in health economics and outcomes research, currently serving as the Medical Strategy Lead for Adult Cholestasis and Director of Medical Affairs (HEOR/RWE) at Ipsen since January 2022. Nisreen has extensive expertise in developing HEOR strategies, economic models, and payer materials primarily within rare diseases, bladder and prostate cancer, and critical care contexts. Previous roles at Astellas Pharma and Mallinckrodt Pharmaceuticals involved designing scientifically rigorous studies and engaging with key healthcare stakeholders to effectively generate evidence and support product accessibility. Nisreen has received notable awards, such as the Circle of Excellence Award and the STAR Award, reflecting a commitment to excellence in medical affairs. Educational credentials include a Doctor of Pharmacy (Pharm.D.) from Mercer University, an MBA from Stetson University, and a Master of Science in Applied Pharmacoeconomics from the University of Florida.